Mark J. Forchette has more than two decades of experience in ophthalmic sales, marketing and business unit management. Immediately prior to OptiMedica, he served as vice president of global marketing and sales for the vitreoretinal business unit of Alcon. In this position, he led the vitreoretinal unit through a period of substantial portfolio enhancement, infrastructure development, and significant increase in market share. 

Prior to Alcon, Forchette was vice president of sales and marketing at Grieshaber & Co., where he led the privately held Swiss company’s domestic operations through major infrastructure and revenue expansion. Grieshaber, which was acquired by Alcon in 1998, remains a significant contributor to Alcon’s successful vitreoretinal portfolio of products. Forchette received a BS in marketing from Auburn University and completed the Harvard Program for Management Development.

Greg Anderson has more than two decades of ophthalmic and surgical sales management experience. Prior to OptiMedica, he served as vice president of U.S. sales for IntraLase, a leading U.S. manufacturer of femtosecond laser technology acquired by AMO in 2007. While at IntraLase, Anderson managed and directed growth and infrastructure, maximizing sales efforts and market share penetration. 

Anderson served previously as vice president of sales and marketing at WaveLight Technologies AG, a German manufacturer of ophthalmic excimer lasers. In this position, he managed the successful U.S. launch of the company’s refractive laser platform, the Allegretto. WaveLight was acquired in 2007 by Alcon.

He also worked for 16 years at Coherent Medical Group, which later merged with Lumenis. While serving as director of North American sales, he was responsible for developing the company’s refractive business unit in the United States. Early in his career, he held a variety of medical and surgical sales positions at companies such as American V. Mueller and Baxter Travenol. Anderson received a BS in marketing from the University of Maryland.

Robert Eno has more than 15 years experience in medical device marketing, sales and strategic planning. Prior to OptiMedica, Eno was vice president of marketing for NeoGuide Systems, a developer of robotically assisted endoscopes. He also served as vice president of marketing and sales for Avantec Vascular, a company that develops interventional cardiology products. From 1994 to 2000, Eno held a series of marketing and strategic planning positions in the vascular intervention division at Guidant. Eno received a BA in economics and American studies with honors and distinction from Stanford University and an MBA from the Stanford University Graduate School of Business.

Robert Haddad has more than 25 years of medical equipment and high-technology operations and general management experience. Prior to OptiMedica, he was vice president of international operations and business development for Elkin Medical Systems, a world leader in digital radiology and PACS products. 

Prior to Elkin, Haddad was the COO and cofounder of Translucent Photonics where he raised $9 million in venture capital to build a world-class materials science research organization that generated IP for the semiconductor industry. He was previously vice president of operations and product development at Sunrise Technologies and vice president of operations at Iridex. He also worked for Coherent as the director of global corporate services. Haddad received a BS in Industrial Engineering & Management from California State Polytechnic University, San Luis Obispo and an MBA from Sacramento State University.

Dr. George Marcellino brings to OptiMedica more than 30 years experience in the medical device industry. Widely known in the ophthalmic community, he has coordinated a number of research efforts in areas such as cataract surgery, pattern scan photocoagulation, selective laser trabeculoplasty (SLT) for the treatment of glaucoma, photodynamic therapy (PDT) for the treatment of exudative age-related macular degeneration and selective retinal therapy. 

Prior to co-founding OptiMedica, Dr. Marcellino was senior director of research at Lumenis. Before Lumenis, he directed worldwide sales and marketing organizations and headed the clinical research and development efforts at Coherent Medical Group. While in this position, he managed a 100-person sales and marketing team and helped establish many innovative products, including the Novus 2000 Photocoagulator, the Laser Indirect Ophthalmoscope and the Laserlink delivery system.

Dr. Marcellino has authored 26 peer-reviewed articles in scientific journals and two textbook chapters and is an inventor on four patents. He received his BS, MS and PhD in sensory physiology and psychophysics from the City University of New York.

Alan Marquardt brings to OptiMedica more than two decades of senior management experience in the medical device industry. Prior to OptiMedica, he held senior leadership positions at companies including EP Technologies, Boston Scientific, Uro Quest Medical, Endovascular Solutions, Kyphon, Pfizer, Schneider U.S. Stent Division and Medtronic. Marquardt received a BS in microbiology from the University of Minnesota.

Mark A. Murray has more than 25 years of senior financial experience in the medical device sector. He brings to OptiMedica a wealth of knowledge and expertise in financial planning, accounting controls and compliance, operations, and mergers and acquisitions. 

Prior to OptiMedica, Murray spent more than 20 years at Guidant where he held numerous officer-level financial and business development positions. Murray was also previously chief financial officer and vice president of finance and administration for Emphasys Medical, an emerging interventional pulmonology company. He began his career at the accounting firms Ernst & Whinney and Main Hurdman. Murray received a BS with emphasis in accounting from San Francisco State University. He is a certified public accountant.

David Scott is a seasoned scientist and medical device executive with 18 years of engineering program management and product development experience. Prior to joining OptiMedica, Scott served as director of imaging systems at Intuitive Surgical, where he led the team responsible for designing, developing and bringing to market next generation vision technology for the da Vinci^® robotic surgical system. His expertise spans a broad range of sophisticated medical technologies, including laser scanning systems, computed tomography, robotics, precision motion control, spectroscopy, imaging, signal processing, ultrasound and x-ray computed tomography (CT). Before Intuitive Surgical, Scott held leadership positions at emerging medical technology companies Varioscale Inc. and Xradia. He was also a staff scientist with the Medical Technology Program and Center for Advanced Signal and Image Sciences at Lawrence Livermore National Laboratory. Dave received a BS in aerospace engineering from the University of Kansas and an MS in aerospace/medical engineering from the University of Colorado, Boulder.